Important safety & regulatory information
CAPO Health is a technology platform. CAPO Health is not a pharmacy and does not practice medicine.
Medical services are provided by independent, state-licensed healthcare providers who exercise their own clinical
judgment. Prescriptions are issued only after a provider reviews your information and determines
that treatment is appropriate for you. Not everyone qualifies, and no treatment, outcome or
eligibility is guaranteed.
Medications referenced on this site are compounded preparations prepared by U.S. pharmacies
licensed in the state where they dispense. Compounded drugs are not approved by the FDA and are
not evaluated by the FDA for safety, effectiveness or quality. They are not generic versions of, nor
equivalent to, Ozempic®, Wegovy®, Mounjaro® or Zepbound®. CAPO Health is not affiliated with, endorsed by
or sponsored by Novo Nordisk A/S or Eli Lilly and Company. All trademarks are the property of their respective owners.
GLP-1 receptor agonists carry risks, including but not limited to nausea, vomiting, diarrhea, constipation,
pancreatitis, gallbladder disease and, in animal studies, thyroid C-cell tumors. Discuss your full medical history,
including any personal or family history of medullary thyroid carcinoma or MEN 2, with your provider.
This website does not provide medical advice and is not a substitute for consultation with a qualified clinician.
In an emergency, call 911.
Weight figures, timelines and projections shown anywhere on this page are illustrative and drawn
from published clinical literature, not from CAPO Health patient outcomes. Individual results vary.
Pricing shown is a starting point; your provider confirms the plan and final price after review.
This site collects no protected health information — intake happens inside the secure, HIPAA-compliant patient portal.
Pending confirmation with CAPO: dispensing pharmacy names and license numbers, medical group name,
LegitScript / NABP / PCAB certification IDs, legal entity and registered address, final pricing, intake URL,
and the published policy documents linked below.